| Symbol | Company | Owner | Relationship | Date | Transaction | Cost | # Shares | Value ($) | Total Shares | Filing | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| CRSP | CRISPR Therapeutics AG | Kulkarni Samarth | Chief Executive Officer | Apr 15, 2024 | Sale | $59.91 | 19,582 | 1,173,232 | 209,326 | Apr 17, 2024, 05:45 PM | |
| CRSP | CRISPR Therapeutics AG | Kulkarni Samarth | Chief Executive Officer | Apr 15, 2024 | Option Exercise | $19.12 | 19,582 | 374,408 | 227,704 | Apr 17, 2024, 05:45 PM | |
| CRSP | CRISPR Therapeutics AG | Kulkarni Samarth | Chief Executive Officer | Mar 15, 2024 | Option Exercise | $19.12 | 20,000 | 382,400 | 228,122 | Mar 18, 2024, 05:45 PM | |
| CRSP | CRISPR Therapeutics AG | Kulkarni Samarth | Chief Executive Officer | Mar 15, 2024 | Sale | $72.48 | 20,000 | 1,449,628 | 217,509 | Mar 18, 2024, 05:45 PM | |
| CRSP | CRISPR Therapeutics AG | Kulkarni Samarth | Chief Executive Officer | Mar 11, 2024 | Sale | $78.26 | 9,802 | 767,105 | 203,705 | Mar 12, 2024, 05:45 PM | |
| CRSP | CRISPR Therapeutics AG | Kulkarni Samarth | Chief Executive Officer | Mar 12, 2024 | Sale | $74.44 | 4,583 | 341,159 | 208,122 | Mar 12, 2024, 05:45 PM | |
| CRSP | CRISPR Therapeutics AG | Kulkarni Samarth | Chief Executive Officer | Feb 20, 2024 | Sale | $79.67 | 6,370 | 507,498 | 194,257 | Feb 21, 2024, 05:45 PM | |
| CRSP | CRISPR Therapeutics AG | Kulkarni Samarth | Chief Executive Officer | Feb 15, 2024 | Sale | $80.36 | 20,000 | 1,607,177 | 194,428 | Feb 16, 2024, 05:45 PM | |
| CRSP | CRISPR Therapeutics AG | Kulkarni Samarth | Chief Executive Officer | Feb 15, 2024 | Option Exercise | $19.12 | 20,000 | 382,400 | 207,377 | Feb 16, 2024, 05:45 PM | |
| CRSP | CRISPR Therapeutics AG | Kulkarni Samarth | Chief Executive Officer | Jan 29, 2024 | Option Exercise | $19.12 | 50,000 | 956,000 | 237,377 | Jan 31, 2024, 05:45 PM | |
| CRSP | CRISPR Therapeutics AG | Kulkarni Samarth | Chief Executive Officer | Jan 29, 2024 | Sale | $60.51 | 50,000 | 3,025,573 | 188,077 | Jan 31, 2024, 05:45 PM | |
| CRSP | CRISPR Therapeutics AG | Kulkarni Samarth | Chief Executive Officer | Jan 16, 2024 | Option Exercise | $19.12 | 20,000 | 382,400 | 207,377 | Jan 18, 2024, 05:45 PM | |
| CRSP | CRISPR Therapeutics AG | Kulkarni Samarth | Chief Executive Officer | Jan 16, 2024 | Sale | $62.50 | 20,000 | 1,250,058 | 187,377 | Jan 18, 2024, 05:45 PM | |
| CRSP | CRISPR Therapeutics AG | Kulkarni Samarth | Chief Executive Officer | May 30, 2023 | Option Exercise | $19.12 | 25,000 | 478,000 | 412,377 | Jun 01, 2023, 05:44 PM | |
| CRSP | CRISPR Therapeutics AG | Kulkarni Samarth | Chief Executive Officer | May 30, 2023 | Sale | $64.88 | 25,000 | 1,621,894 | 405,076 | Jun 01, 2023, 05:44 PM | |
| CRSP | CRISPR Therapeutics AG | Kulkarni Samarth | Chief Executive Officer | Apr 25, 2023 | Option Exercise | $19.12 | 25,000 | 478,000 | 412,377 | Apr 27, 2023, 05:37 PM | |
| CRSP | CRISPR Therapeutics AG | Kulkarni Samarth | Chief Executive Officer | Apr 25, 2023 | Sale | $50.67 | 25,000 | 1,266,638 | 391,770 | Apr 27, 2023, 05:37 PM | |
| CRSP | CRISPR Therapeutics AG | Kulkarni Samarth | Chief Executive Officer | Mar 29, 2023 | Sale | $44.46 | 25,000 | 1,111,503 | 392,658 | Mar 31, 2023, 05:49 PM | |
| CRSP | CRISPR Therapeutics AG | Kulkarni Samarth | Chief Executive Officer | Mar 29, 2023 | Option Exercise | $19.12 | 25,000 | 478,000 | 412,377 | Mar 31, 2023, 05:49 PM | |
| CRSP | CRISPR Therapeutics AG | Kulkarni Samarth | Chief Executive Officer | Mar 13, 2023 | Option Exercise | $43.22 | 9,444 | 408,170 | 387,377 | Mar 14, 2023, 05:47 PM | |
| CRSP | CRISPR Therapeutics AG | Kulkarni Samarth | Chief Executive Officer | Feb 27, 2023 | Option Exercise | $19.12 | 25,000 | 478,000 | 400,988 | Mar 01, 2023, 06:11 PM | |
| CRSP | CRISPR Therapeutics AG | Kulkarni Samarth | Chief Executive Officer | Feb 27, 2023 | Sale | $48.25 | 25,000 | 1,206,243 | 390,808 | Mar 01, 2023, 06:11 PM | |
| CRSP | CRISPR Therapeutics AG | Kulkarni Samarth | Chief Executive Officer | Feb 21, 2023 | Option Exercise | $48.26 | 6,373 | 307,561 | 375,988 | Feb 22, 2023, 05:38 PM | |
| CRSP | CRISPR Therapeutics AG | Kulkarni Samarth | Chief Executive Officer | Jan 27, 2023 | Sale | $51.47 | 25,000 | 1,286,797 | 392,311 | Jan 31, 2023, 05:34 PM | |
| CRSP | CRISPR Therapeutics AG | Kulkarni Samarth | Chief Executive Officer | Jan 27, 2023 | Option Exercise | $19.12 | 25,000 | 478,000 | 394,111 | Jan 31, 2023, 05:34 PM | |
| CRSP | CRISPR Therapeutics AG | Kulkarni Samarth | Chief Executive Officer | Dec 28, 2022 | Option Exercise | $19.12 | 25,000 | 478,000 | 394,111 | Dec 30, 2022, 05:33 PM | |
| CRSP | CRISPR Therapeutics AG | Kulkarni Samarth | Chief Executive Officer | Dec 28, 2022 | Sale | $40.93 | 25,000 | 1,023,290 | 373,745 | Dec 30, 2022, 05:33 PM | |
| CRSP | CRISPR Therapeutics AG | Kulkarni Samarth | Chief Executive Officer | Dec 06, 2022 | Option Exercise | $1.81 | 58,233 | 105,402 | 369,111 | Dec 08, 2022, 05:35 PM | |
| CRSP | CRISPR Therapeutics AG | Kulkarni Samarth | Chief Executive Officer | Dec 05, 2022 | Option Exercise | $52.26 | 19,401 | 1,013,896 | 310,878 | Dec 06, 2022, 05:49 PM | |
| CRSP | CRISPR Therapeutics AG | Kulkarni Samarth | Chief Executive Officer | Nov 28, 2022 | Option Exercise | $19.12 | 25,000 | 478,000 | 315,279 | Nov 30, 2022, 05:36 PM | |
| CRSP | CRISPR Therapeutics AG | Kulkarni Samarth | Chief Executive Officer | Nov 28, 2022 | Sale | $54.03 | 25,000 | 1,350,827 | 298,161 | Nov 30, 2022, 05:36 PM | |
| CRSP | CRISPR Therapeutics AG | Kulkarni Samarth | Chief Executive Officer | Oct 26, 2022 | Option Exercise | $16.84 | 25,000 | 421,016 | 315,279 | Oct 28, 2022, 05:43 PM | |
| CRSP | CRISPR Therapeutics AG | Kulkarni Samarth | Chief Executive Officer | Oct 26, 2022 | Sale | $54.81 | 25,000 | 1,370,191 | 312,779 | Oct 28, 2022, 05:43 PM | |
| CRSP | CRISPR Therapeutics AG | Kulkarni Samarth | Chief Executive Officer | Sep 28, 2022 | Sale | $64.61 | 25,000 | 1,615,160 | 292,079 | Sep 30, 2022, 05:42 PM | |
| CRSP | CRISPR Therapeutics AG | Kulkarni Samarth | Chief Executive Officer | Sep 28, 2022 | Option Exercise | $16.21 | 25,000 | 405,250 | 315,279 | Sep 30, 2022, 05:42 PM | |
| CRSP | CRISPR Therapeutics AG | Kulkarni Samarth | Chief Executive Officer | Aug 29, 2022 | Option Exercise | $16.21 | 25,000 | 405,250 | 315,279 | Aug 31, 2022, 05:45 PM | |
| CRSP | CRISPR Therapeutics AG | Kulkarni Samarth | Chief Executive Officer | Aug 29, 2022 | Sale | $66.84 | 25,000 | 1,671,084 | 311,206 | Aug 31, 2022, 05:45 PM | |
| CRSP | CRISPR Therapeutics AG | Kulkarni Samarth | Chief Executive Officer | Jul 27, 2022 | Option Exercise | $15.00 | 25,000 | 374,918 | 315,279 | Jul 29, 2022, 05:38 PM | |
| CRSP | CRISPR Therapeutics AG | Kulkarni Samarth | Chief Executive Officer | Jul 27, 2022 | Sale | $75.91 | 25,000 | 1,897,747 | 308,346 | Jul 29, 2022, 05:38 PM | |
| CRSP | CRISPR Therapeutics AG | Kulkarni Samarth | Chief Executive Officer | Jun 29, 2022 | Sale | $61.59 | 25,000 | 1,539,861 | 295,019 | Jul 01, 2022, 06:00 PM | |
| CRSP | CRISPR Therapeutics AG | Kulkarni Samarth | Chief Executive Officer | Jun 29, 2022 | Option Exercise | $12.57 | 25,000 | 314,250 | 315,279 | Jul 01, 2022, 06:00 PM | |
| CRSP | CRISPR Therapeutics AG | Kulkarni Samarth | Chief Executive Officer | Mar 11, 2022 | Option Exercise | $62.56 | 5,487 | 343,267 | 285,432 | Mar 14, 2022, 06:12 PM | |
| CRSP | CRISPR Therapeutics AG | Kulkarni Samarth | Chief Executive Officer | Mar 14, 2022 | Option Exercise | $61.08 | 4,153 | 253,665 | 290,279 | Mar 14, 2022, 06:12 PM | |
| CRSP | CRISPR Therapeutics AG | Kulkarni Samarth | Chief Executive Officer | Dec 20, 2021 | Option Exercise | $1.81 | 17,750 | 32,127 | 279,085 | Dec 22, 2021, 08:00 PM | |
| CRSP | CRISPR Therapeutics AG | Kulkarni Samarth | Chief Executive Officer | Dec 06, 2021 | Option Exercise | $69.17 | 37,818 | 2,615,871 | 261,335 | Dec 07, 2021, 08:00 PM | |
| CRSP | CRISPR Therapeutics AG | Kulkarni Samarth | Chief Executive Officer | Dec 01, 2021 | Option Exercise | $75.10 | 779 | 58,503 | 219,153 | Dec 03, 2021, 08:00 PM | |
| CRSP | CRISPR Therapeutics AG | Kulkarni Samarth | Chief Executive Officer | Oct 15, 2021 | Option Exercise | $1.81 | 33,000 | 59,730 | 219,932 | Oct 18, 2021, 08:00 PM | |
| CRSP | CRISPR Therapeutics AG | Kulkarni Samarth | Chief Executive Officer | Sep 01, 2021 | Option Exercise | $124.83 | 787 | 98,241 | 186,932 | Sep 03, 2021, 08:00 PM | |
| CRSP | CRISPR Therapeutics AG | Kulkarni Samarth | Chief Executive Officer | Aug 05, 2021 | Option Exercise | $12.57 | 28,500 | 358,245 | 216,219 | Aug 06, 2021, 08:00 PM | |
| CRSP | CRISPR Therapeutics AG | Kulkarni Samarth | Chief Executive Officer | Aug 05, 2021 | Sale | $128.98 | 28,500 | 3,675,939 | 215,219 | Aug 06, 2021, 08:00 PM | |
| CRSP | CRISPR Therapeutics AG | Kulkarni Samarth | Chief Executive Officer | Aug 04, 2021 | Option Exercise | $12.57 | 1,500 | 18,855 | 189,219 | Aug 06, 2021, 08:00 PM | |
| CRSP | CRISPR Therapeutics AG | Kulkarni Samarth | Chief Executive Officer | Aug 04, 2021 | Sale | $125.02 | 1,500 | 187,530 | 187,719 | Aug 06, 2021, 08:00 PM | |
| CRSP | CRISPR Therapeutics AG | Kulkarni Samarth | Chief Executive Officer | Jun 15, 2021 | Option Exercise | $12.57 | 30,000 | 377,100 | 217,719 | Jun 17, 2021, 05:44 PM | |
| CRSP | CRISPR Therapeutics AG | Kulkarni Samarth | Chief Executive Officer | Jun 15, 2021 | Sale | $126.43 | 30,000 | 3,792,804 | 207,336 | Jun 17, 2021, 05:44 PM | |
| CRSP | CRISPR Therapeutics AG | Kulkarni Samarth | Chief Executive Officer | Mar 10, 2021 | Option Exercise | $124.15 | 5,526 | 686,053 | 188,498 | Mar 12, 2021, 05:49 PM | |
| CRSP | CRISPR Therapeutics AG | Kulkarni Samarth | Chief Executive Officer | Mar 01, 2021 | Option Exercise | $130.25 | 798 | 103,940 | 182,191 | Mar 03, 2021, 04:13 PM | |
| CRSP | CRISPR Therapeutics AG | Kulkarni Samarth | Chief Executive Officer | Jan 15, 2021 | Sale | $213.67 | 20,000 | 4,273,311 | 199,849 | Jan 20, 2021, 06:11 PM | |
| CRSP | CRISPR Therapeutics AG | Kulkarni Samarth | Chief Executive Officer | Jan 15, 2021 | Option Exercise | $1.81 | 20,000 | 36,200 | 202,989 | Jan 20, 2021, 06:11 PM | |
| CRSP | CRISPR Therapeutics AG | Kulkarni Samarth | Chief Executive Officer | Dec 29, 2020 | Option Exercise | $1.81 | 13,800 | 24,978 | 182,989 | Dec 30, 2020, 04:02 PM | |
| CRSP | CRISPR Therapeutics AG | Kulkarni Samarth | Chief Executive Officer | Dec 10, 2020 | Option Exercise | $1.81 | 20,000 | 36,200 | 189,189 | Dec 11, 2020, 04:05 PM | |
| CRSP | CRISPR Therapeutics AG | Kulkarni Samarth | Chief Executive Officer | Dec 10, 2020 | Sale | $142.29 | 20,000 | 2,845,782 | 183,689 | Dec 11, 2020, 04:05 PM | |
| CRSP | CRISPR Therapeutics AG | Kulkarni Samarth | Chief Executive Officer | Dec 01, 2020 | Option Exercise | $129.58 | 779 | 100,943 | 169,189 | Dec 03, 2020, 04:32 PM | |
| CRSP | CRISPR Therapeutics AG | Kulkarni Samarth | Chief Executive Officer | Sep 02, 2020 | Option Exercise | $94.15 | 779 | 73,343 | 169,968 | Sep 03, 2020, 04:42 PM | |
| CRSP | CRISPR Therapeutics AG | Kulkarni Samarth | Chief Executive Officer | Jun 01, 2020 | Option Exercise | $1.81 | 17,275 | 31,268 | 188,801 | Jun 03, 2020, 05:32 PM | |
| CRSP | CRISPR Therapeutics AG | Kulkarni Samarth | Chief Executive Officer | Jun 01, 2020 | Sale | $64.68 | 17,275 | 1,117,266 | 186,401 | Jun 03, 2020, 05:32 PM | |
| CRSP | CRISPR Therapeutics AG | Kulkarni Samarth | Chief Executive Officer | Jun 02, 2020 | Option Exercise | $66.26 | 779 | 51,617 | 170,747 | Jun 03, 2020, 05:32 PM | |
| CRSP | CRISPR Therapeutics AG | Kulkarni Samarth | Chief Executive Officer | May 20, 2020 | Sale | $65.28 | 10,693 | 698,039 | 171,526 | May 21, 2020, 04:35 PM | |
| CRSP | CRISPR Therapeutics AG | Kulkarni Samarth | Chief Executive Officer | May 19, 2020 | Option Exercise | $1.81 | 4,307 | 7,796 | 175,833 | May 21, 2020, 04:35 PM | |
| CRSP | CRISPR Therapeutics AG | Kulkarni Samarth | Chief Executive Officer | May 19, 2020 | Sale | $65.16 | 4,307 | 280,644 | 171,526 | May 21, 2020, 04:35 PM | |
| CRSP | CRISPR Therapeutics AG | Kulkarni Samarth | Chief Executive Officer | May 20, 2020 | Option Exercise | $1.81 | 10,693 | 19,354 | 182,219 | May 21, 2020, 04:35 PM | |
| CRSP | CRISPR Therapeutics AG | Kulkarni Samarth | Chief Executive Officer | Mar 02, 2020 | Option Exercise | $52.74 | 794 | 41,876 | 171,526 | Mar 04, 2020, 04:26 PM | |
| CRSP | CRISPR Therapeutics AG | Kulkarni Samarth | Chief Executive Officer | Dec 16, 2019 | Option Exercise | $1.81 | 8,000 | 14,480 | 172,320 | Dec 18, 2019, 04:05 PM | |
| CRSP | CRISPR Therapeutics AG | Kulkarni Samarth | Chief Executive Officer | Dec 01, 2019 | Option Exercise | $71.65 | 741 | 53,093 | 164,320 | Dec 02, 2019, 05:12 PM | |
| CRSP | CRISPR Therapeutics AG | Kulkarni Samarth | Chief Executive Officer | Sep 01, 2019 | Option Exercise | $46.21 | 740 | 34,195 | 165,061 | Sep 03, 2019, 04:23 PM | |
| CRSP | CRISPR Therapeutics AG | Kulkarni Samarth | Chief Executive Officer | Jun 17, 2019 | Option Exercise | $1.81 | 20,000 | 36,200 | 185,801 | Jun 19, 2019, 04:15 PM | |
| CRSP | CRISPR Therapeutics AG | Kulkarni Samarth | Chief Executive Officer | Jun 17, 2019 | Sale | $46.00 | 20,000 | 920,000 | 165,801 | Jun 19, 2019, 04:15 PM | |
| CRSP | CRISPR Therapeutics AG | Kulkarni Samarth | Chief Executive Officer | Jun 01, 2019 | Option Exercise | $35.57 | 741 | 26,357 | 165,801 | Jun 04, 2019, 04:25 PM | |
| CRSP | CRISPR Therapeutics AG | Kulkarni Samarth | Chief Executive Officer | Apr 29, 2019 | Sale | $42.03 | 20,000 | 840,600 | 166,542 | May 01, 2019, 04:05 PM | |
| CRSP | CRISPR Therapeutics AG | Kulkarni Samarth | Chief Executive Officer | Apr 29, 2019 | Option Exercise | $1.81 | 20,000 | 36,200 | 186,542 | May 01, 2019, 04:05 PM | |
| CRSP | CRISPR Therapeutics AG | Kulkarni Samarth | Chief Executive Officer | Mar 01, 2019 | Option Exercise | $39.97 | 748 | 29,898 | 166,542 | Mar 05, 2019, 05:57 PM | |
| CRSP | CRISPR Therapeutics AG | Kulkarni Samarth | Chief Executive Officer | Dec 07, 2018 | Option Exercise | $1.81 | 21,500 | 38,915 | 167,290 | Dec 11, 2018, 04:29 PM | |
| CRSP | CRISPR Therapeutics AG | Kulkarni Samarth | Chief Executive Officer | Dec 01, 2018 | Option Exercise | $38.33 | 741 | 28,403 | 145,790 | Dec 03, 2018, 05:29 PM | |
| CRSP | CRISPR Therapeutics AG | Kulkarni Samarth | Chief Executive Officer | Sep 01, 2018 | Option Exercise | $56.67 | 741 | 41,992 | 146,531 | Sep 04, 2018, 06:33 PM | |
| CRSP | CRISPR Therapeutics AG | Kulkarni Samarth | Chief Executive Officer | Jun 01, 2018 | Option Exercise | $1.81 | 15,000 | 27,150 | 163,560 | Jun 05, 2018, 08:20 PM | |
| CRSP | CRISPR Therapeutics AG | Kulkarni Samarth | Chief Executive Officer | Jun 01, 2018 | Sale | $69.36 | 15,000 | 1,040,400 | 158,960 | Jun 05, 2018, 08:20 PM | |
| CRSP | CRISPR Therapeutics AG | Kulkarni Samarth | Chief Executive Officer | Jun 04, 2018 | Option Exercise | $67.13 | 741 | 49,743 | 147,819 | Jun 05, 2018, 08:20 PM | |
| CRSP | CRISPR Therapeutics AG | Kulkarni Samarth | Chief Executive Officer | Dec 21, 2017 | Option Exercise | $1.81 | 15,000 | 27,150 | 148,560 | Dec 26, 2017, 05:11 PM | |
| CRSP | CRISPR Therapeutics AG | Kulkarni Samarth | Chief Executive Officer | Dec 01, 2017 | Option Exercise | $19.12 | 26,667 | 509,873 | 133,560 | Dec 05, 2017, 04:19 PM | |
| CRSP | CRISPR Therapeutics AG | Kulkarni Samarth | Chief Business Officer | Aug 30, 2017 | Sale | $20.00 | 4,000 | 80,000 | 106,893 | Aug 30, 2017, 06:12 PM | |
| CRSP | CRISPR Therapeutics AG | Kulkarni Samarth | Chief Business Officer | Aug 28, 2017 | Sale | $20.09 | 23,154 | 465,162 | 110,893 | Aug 30, 2017, 06:12 PM | |
| CRSP | CRISPR Therapeutics AG | Kulkarni Samarth | Chief Business Officer | Apr 26, 2017 | Option Exercise | $1.81 | 3,275 | 5,928 | 137,322 | Apr 28, 2017, 06:13 PM | |
| CRSP | CRISPR Therapeutics AG | Kulkarni Samarth | Chief Business Officer | Apr 26, 2017 | Sale | $16.74 | 3,275 | 54,816 | 134,047 | Apr 28, 2017, 06:13 PM | |
| CRSP | CRISPR Therapeutics AG | Kulkarni Samarth | Chief Business Officer | Apr 27, 2017 | Option Exercise | $1.81 | 2,206 | 3,993 | 136,253 | Apr 28, 2017, 06:13 PM | |
| CRSP | CRISPR Therapeutics AG | Kulkarni Samarth | Chief Business Officer | Apr 27, 2017 | Sale | $16.78 | 2,206 | 37,023 | 134,047 | Apr 28, 2017, 06:13 PM | |
| CRSP | CRISPR Therapeutics AG | Kulkarni Samarth | Chief Business Officer | Apr 21, 2017 | Sale | $17.01 | 3,000 | 51,033 | 134,047 | Apr 25, 2017, 07:36 PM | |
| CRSP | CRISPR Therapeutics AG | Kulkarni Samarth | Chief Business Officer | Apr 24, 2017 | Option Exercise | $1.81 | 3,500 | 6,335 | 137,547 | Apr 25, 2017, 07:36 PM | |
| CRSP | CRISPR Therapeutics AG | Kulkarni Samarth | Chief Business Officer | Apr 24, 2017 | Sale | $16.46 | 3,500 | 57,619 | 134,047 | Apr 25, 2017, 07:36 PM | |
| CRSP | CRISPR Therapeutics AG | Kulkarni Samarth | Chief Business Officer | Apr 25, 2017 | Option Exercise | $1.81 | 5,115 | 9,258 | 139,162 | Apr 25, 2017, 07:36 PM | |
| CRSP | CRISPR Therapeutics AG | Kulkarni Samarth | Chief Business Officer | Apr 25, 2017 | Sale | $16.87 | 5,115 | 86,290 | 134,047 | Apr 25, 2017, 07:36 PM | |
| CRSP | CRISPR Therapeutics AG | Kulkarni Samarth | Chief Business Officer | Apr 21, 2017 | Option Exercise | $1.81 | 3,000 | 5,430 | 137,047 | Apr 25, 2017, 07:36 PM |
Menu